
Bioimmuno Labs Private Limited
About Bioimmuno Labs Private Limited
Data last updated:
Bioimmuno Labs Private Limited is a private limited company based in Kolkata, West Bengal, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 25 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85300WB2018PTC226287.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Manash Dey and Papri Dey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 29/2 S.M. Ali Road Barrackpore, Kolkata, West Bengal, India – 700120.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.82 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹3,028 (net margin 0.2%) and EBITDA of ₹22,645 (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 19% over five years.
Company details
Recognitions & Rankings of Bioimmuno Labs
Contact details
Bioimmuno Labs Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address29/2 S.M. Ali Road Barrackpore, Kolkata, West Bengal, India – 700120
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Bioimmuno Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioimmuno Labs is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Bioimmuno Labs Private Limited, buy the company report.
Financials of Bioimmuno Labs Private Limited
FY 2025 filings availableBioimmuno Labs Private Limited reported revenue of ₹18.82 Lakh (down 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 36% fall in the latest year. EBITDA fell 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,645 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,028 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioimmuno Labs Private Limited, buy the company report.
Board of directors of Bioimmuno Labs Private Limited
Bioimmuno Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manash Dey Also directs: Care and Cure Nursing Home Private Limited | Director | 25 May 2018 | 8 Years 5 Months | Current |
| Papri Dey | Director | 05 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Bioimmuno Labs Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lions 321 A2 Foundation | ₹19.33 Lakh (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Bioimmuno Labs Private Limitedthis company | ₹18.82 Lakh (FY 2025) | ₹3,028 | 0.2% | -36.0% | Kolkata, West Bengal, India | |
| Gitaansh Healthwise Private Limited | ₹18.71 Lakh (FY 2024) | 85.0% | Mumbai, Maharashtra, India | |||
| Xperiarad Solutions Private Limited | ₹18.67 Lakh (FY 2025) | 657.0% | Aluva, Kerala, India | |||
| Matrix Hospitals and Research Centre Private Limited | ₹18.61 Lakh (FY 2024) | 13.0% | Kolhapur, Maharashtra, India |
To see the full peer comparison of Bioimmuno Labs Private Limited, buy the company report.
Auditor
Bioimmuno Labs Private Limited is audited by S C SWAIKA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S C SWAIKA & CO | FY 2020 | 322137E |
Shareholding
The shareholding of Bioimmuno Labs Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bioimmuno Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioimmuno Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioimmuno Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bioimmuno Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bioimmuno Labs Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Papri Dey was appointed as Director on 05 Feb 2019.
Frequently asked questions
Bioimmuno Labs is an active private limited company based in Kolkata, West Bengal, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 25 May 2018 (8+ years old) and is registered under CIN U85300WB2018PTC226287.
Bioimmuno Labs has 2 current directors:
- Manash Dey - Director
- Papri Dey - Director
The latest financial statements of Bioimmuno Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Bioimmuno Labs is U85300WB2018PTC226287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioimmuno Labs was incorporated on 25 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Bioimmuno Labs by revenue are Lions 321 A2 Foundation, Gitaansh Healthwise Private Limited, Xperiarad Solutions Private Limited, Matrix Hospitals and Research Centre Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (human health activities).
Papri Dey was appointed as Director on 05 Feb 2019. Jayanta Chowdhury ceased to be Director on 04 Feb 2019. Jayanta Chowdhury was appointed as Director on 25 May 2018. Bioimmuno Labs has 4 board changes on record in total.
Yes, Bioimmuno Labs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Bioimmuno Labs is at 292 S.M. Ali Road Barrackpore, Kolkata, West Bengal, India – 700120.
Bioimmuno Labs operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Bioimmuno Labs can be reached at its registered office: 292 S.M. Ali Road Barrackpore, Kolkata, West Bengal, India – 700120.